Smurfit Westrock PLC SW 深 沪
等待开盘 03-26 09:30:00 美东时间
40.67
+0.810
+2.03%
华盛通- 最 高40.72
- 今 开40.33
- 成交量 606.55万股
- 最 低 39.43
- 昨 收 39.86
- 总市值 213.21亿
- 52周最高 52.22
- 市盈率 静 30.60
- 换手率 1.16%
- 52周最低 32.2767
- 委 比 -86.92%
- 总股本 5.24亿
- 历史最高 54.8102
- 量 比 0.82
- 振 幅 3.24%
- 历史最低 32.2767
- 每 手 1
- 风险率 3.68%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 小摩、瑞穗等下调阿里目标价最低至164美元；达登饭店、联邦快递、林肯教育服务、Planet Labs等获多家大行上调目标价
今日重点评级关注：瑞穗：维持RELMADA THERAPEUTICS"跑赢大市"评级，目标价从10美元升至19美元；奥本海默：维持Pelthos Therapeutics"跑赢大市"评级，目标价从60美元升至62美元
03-23 13:53
Wells Fargo Maintains Overweight on Smurfit WestRock, Lowers Price Target to $50
Wells Fargo analyst Gabe Hajde maintains Smurfit WestRock (NYSE:SW) with a Overweight and lowers the price target from $55 to $50.
03-20 22:23
Earnings Scheduled For March 12, 2026
Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is likel...
03-12 19:11
美股大行评级 | 潜在涨幅183%！迈威尔科技获10家机构上调目标价最高至164美元；伯灵顿百货、好市多、Ciena、Samsara等获多家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持BridgeBio Oncology"买入"评级，目标价从27美元升至29美元；韦德布什：维持WAVE Life Sciences"跑赢大市"评级，目标价从33美元升至35美元
03-09 11:47
Forecasting The Future: 9 Analyst Projections For Smurfit WestRock
Smurfit WestRock (NYSE:SW) has been analyzed by 9 analysts in the last three mo...
03-07 03:00
Morgan Stanley Maintains Overweight on Smurfit WestRock, Lowers Price Target to $60
Morgan Stanley analyst Brian Morton maintains Smurfit WestRock (NYSE:SW) with a Overweight and lowers the price target from $61 to $60.
03-07 00:01
财报速睇 | Smurfit Westrock PLC 2025财年年度营收311.79亿美元，同比增长47.7%；归母净利润6.99亿美元，同比增长119.1%
华盛资讯2月27日讯，Smurfit Westrock PLC公布2025财年年度业绩，公司年度营收311.79亿美元，同比增长47.7%，归母净利润6.99亿美元，同比增长119.1%。
02-27 20:17
BUZZ-U.S. STOCKS ON THE MOVE-Merck, Alphabet, JPMorgan Chase
BUZZ-U.S. STOCKS ON THE MOVE-Merck, Alphabet, JPMorgan Chase Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes were set to open lower on Monday as renewed ta
02-23 22:10
Why Vanda Pharmaceuticals Shares Are Trading Higher By Around 33%; Here Are 20 Stocks Moving Premarket
Shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) rose sharply in pre-market t...
02-23 17:57
